MINNEAPOLIS, Aug. 25, 2025 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq:ONMD) (“OneMedNet,” the “Company,” “we,” “us” or “our”), a leader in AI-powered Real-World Data (RWD), announces significant adoption by one of the world’s top five medical device leaders. Renowned for its cutting-edge diagnostic imaging systems, clinical software, and digital health solutions, this global innovator is recognized for advancing precision medicine and improving patient outcomes worldwide. There is a master services a ...

Core Insights - OneMedNet Corporation has expanded its Cardiovascular network by adding 85 new cardiovascular centers and data sources, positioning itself as one of the largest providers of Cardiovascular Real-World Data (RWD) [1][5] Industry Context - Cardiovascular diseases (CVDs) are the leading cause of death globally, responsible for approximately 19.8 million deaths in 2022, which accounts for about 32% of all global mortality [2] - The economic burden of CVD is significant, driving an estimated $320 billion annually in the United States and over $1 trillion globally in direct healthcare costs and lost productivity [2] Company Positioning - The enriched multimodal cardiovascular data network of OneMedNet is well-suited for the pharmaceutical and insurance sectors, providing real-time data that offers deeper insights into disease progression, treatment responses, and outcomes [3] - The expansion enhances OneMedNet's ability to deliver de-identified cardiovascular imaging, diagnostic reports, and electrocardiograms (ECG) at an unprecedented scale, continually updated to reflect the latest clinical insights [4][6] - OneMedNet is positioned as the premier source for high-quality, regulatory-grade cardiovascular RWD, which fuels innovation, supports clinical evidence generation, and improves patient outcomes [5] Technological Advancements - By combining de-identified cardiovascular imaging, structured reports, and ECG signals, OneMedNet provides real-world clinical insights that accelerate innovation in diagnostics, therapeutics, and AI model development [6] - The company utilizes its iRWD™ platform to harness the potential of over 1,750 healthcare sites, delivering precision insights across various medical fields, including cardiology [7]

Company Overview - OneMedNet Corporation is a leader in AI-powered Real-World Data (RWD) and has established a long-term strategic partnership with Circle Cardiovascular Imaging Inc. to enhance cardiac diagnostics and treatment planning [1][4] - Circle CVI selected OneMedNet's iRWD™ platform for access to diverse and regulatory-grade cardiovascular datasets, which includes data from over 1,750 provider sites and over 131 million exams [2][4] Partnership Details - The collaboration allows Circle CVI to expand its research and development capabilities while aligning with evolving regulatory and clinical evidence standards [4] - Circle CVI's CEO highlighted the exceptional quality and regulatory readiness of OneMedNet's data, indicating a commitment to a long-term partnership [3][5] Industry Implications - This partnership exemplifies a growing industry shift towards utilizing real-world evidence as a foundation for medical innovation [4] - OneMedNet's platform is positioned to revolutionize how healthcare companies access and utilize Real-World Data, which is critical for driving innovation in various medical fields [5]

Core Viewpoint - OneMedNet Corporation has successfully raised approximately $3.7 million through private placement transactions at a price of $0.42 per share, with participation from the company's founders and directors [1][2]. Financial Actions - The proceeds from the private placements will be utilized for working capital and general corporate purposes [2]. - The company has achieved a 60% reduction in total liabilities, settling or converting approximately $11.0 million of current liabilities as of March 31, 2025 [3]. - Specific financial actions include settling approximately $3.26 million of deferred underwriter fees, $1.08 million in trade payables, and converting $6.56 million of principal and interest into common stock [8]. Company Overview - OneMedNet is a leader in providing regulatory-grade imaging Real-World Data (iRWD), leveraging data from over 1,400 healthcare sites to drive innovation in healthcare [6]. - The company’s iRWD™ platform supports advancements in various medical fields, including rare diseases, oncology, and cardiology, by delivering precision insights [6]. - Beyond healthcare, OneMedNet's proprietary AI technology anonymizes data for other industries such as finance, retail, and telecom, enhancing data security and project de-risking [7].

Core Insights - OneMedNet Corporation has expanded its capabilities within the Datavant Connect platform to enhance healthcare data discovery, analytics, and partner assessment processes, emphasizing the importance of secure and scalable data solutions in healthcare innovation [1][4] - The healthcare industry is generating vast amounts of health-related data, which is often fragmented and siloed, creating challenges in accessibility and usability [2][5] - OneMedNet will utilize AWS Clean Rooms to provide secure collaboration environments for data partner assessment, enhancing data security and privacy without direct data movement [3][4] Company Overview - OneMedNet is a leader in providing regulatory-grade imaging Real-World Data (iRWD), leveraging over 1,400 healthcare sites to unlock the potential of healthcare data [5] - The company’s iRWD™ platform supports various sectors, including rare diseases, oncology, and cardiology, delivering insights that drive innovation in patient care and healthcare disruption [5][6] - Beyond healthcare, OneMedNet's AI technology anonymizes data for other industries such as finance and retail, enabling secure data sharing and project de-risking [6]

MINNEAPOLIS, April 23, 2025 (GLOBE NEWSWIRE) -- OneMedNet, a leader in AI-powered Real-World Data, has announced a strategic partnership with Protege, the AI training data platform, to enable real-time access, multimodal patient data for AI developers and researchers. Through this collaboration, OneMedNet’s data will be made available via Protege, expanding access to high-quality datasets for building next-generation AI solutions in healthcare. This partnership unlocks the potential for more precise, adapti ...

Core Insights - OneMedNet has partnered with Datavant to enhance access to tokenized, purpose-built data for life sciences and medical research, leveraging a network of 31 million patients and over 121 million clinical studies [1][2] - The integration of OneMedNet's patient tokens into Datavant's ecosystem allows for easier discovery and access to Real-World Data, improving longitudinal data visibility and connectivity for researchers [2][3] - This collaboration emphasizes OneMedNet's leadership in medical innovation through AI and robust platforms, aiming to accelerate evidence-based solutions while ensuring data privacy [3] Company Overview - OneMedNet is transforming the utilization of Real-World Data (RWD) through its iRWD™ platform, which taps into over 1,400 healthcare sites, providing insights that drive innovation in drug development and patient care [4] - The company also applies its proprietary AI to anonymize data for various industries, including finance and retail, showcasing its versatility beyond healthcare [5]

Core Insights - OneMedNet Corporation has appointed Dr. Kenneth Alleyne to its Board of Directors, where he will serve as Chair of the Audit Committee, leveraging his extensive expertise in healthcare, insurance, investment, and corporate governance [1][4] Company Overview - OneMedNet is a leading Real World Data platform that utilizes AI-driven de-identification, aiming to revolutionize the use of healthcare data from over 1,400 healthcare sites through its iRWD™ platform [5] - The company focuses on delivering precision insights that enhance patient care and drive innovation in drug development and medical devices [5] Dr. Kenneth Alleyne's Background - Dr. Alleyne is a board-certified orthopedic surgeon with a specialization in sports medicine and has significant experience in the insurance sector, having co-founded healthcare firms that focus on Medicaid and Medicare Advantage [2] - He has served as a seed investor and founding chief medical officer of VirtualHealth, which manages over 10 million lives, and co-founded Fizio Health, an AI-powered remote physical therapy solution [2] Strategic Implications - Dr. Alleyne's appointment is expected to enhance OneMedNet's iRWD™ platform, providing innovative solutions for the orthopedics sector and empowering insurance companies with actionable insights and cost savings [4]